What is SS-31 (Elamipretide / MTP-131) used for?
SS-31 (Elamipretide / MTP-131) is most commonly used for users with mitochondrial-flavored fatigue; older adults targeting cellular bioenergetics; stack add-ons for hard-training athletes. Boosts your cells' energy production at the source. A mitochondria-targeting peptide that concentrates in the inner mitochondrial membrane to support ATP production, FDA-approved in 2025 as FORZINITY for Barth syndrome, the first mitochondria-targeted drug, with all other uses off-label. Human evidence for SS-31 (Elamipretide / MTP-131) is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use SS-31 (Elamipretide / MTP-131) for
- Users with mitochondrial-flavored fatigue
- Older adults targeting cellular bioenergetics
- Stack add-ons for hard-training athletes
References
- Elamipretide in primary mitochondrial myopathy (MMPOWER trials) — Karaa A et al., Neurology, 2018
- Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER — Thompson WR, Manuel R, Abbruscato A, et al. — Genetics in Medicine, 2024
- FORZINITY (elamipretide hydrochloride) injection — FDA Prescribing Information — FDA / DailyMed (Stealth BioTherapeutics), 2025
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on SS-31 (Elamipretide / MTP-131)
Full SS-31 (Elamipretide / MTP-131) breakdownSS-31 (Elamipretide / MTP-131) side effectsSS-31 (Elamipretide / MTP-131) how to take itSS-31 (Elamipretide / MTP-131) mistakes to avoidSS-31 (Elamipretide / MTP-131) who should avoid itSS-31 (Elamipretide / MTP-131) half-lifeSS-31 (Elamipretide / MTP-131) how long to workSS-31 (Elamipretide / MTP-131) legal statusSS-31 (Elamipretide / MTP-131) how it worksAsk the AI Coach
Last updated 2026-06-15.